Filter by Knowledge Space:
Access to Advanced Health Institute
John Chen
Accelerated Stability and Aerosol Performance Assessment for a Spray Dried Nasal COVID-19 Vaccine CandidateP7
Access to Advanced Health Institute
P2
Amneal Pharmaceuticals
Sunilkumar Patel
The Influence of Temperature and Humidity Control in Laboratory Settings on the Aerodynamic Particle Size Distribution of Soft Mist InhalersP4
Goncalo Farias and Charles Cazzola
Optimization of a Multidose Nasal Actuator Targeting Olfactory Region DepositionP4
Pauline Faucard and Benedicte Grosjean
Leachables Assessment from a New Generation of pMDIs using Low Global Warming Potential Propellants and the Impact of Ethanol FillingP1
Belhaven Biopharma
Brian Taubenheim
Pharmacokinetic Comparison of Nasal Delivered Dry Powdered Epinephrine to an Autoinjector (EpiPen®) in a Canine ModelP3
Sabrina Falloon
Using Human Factors Studies to Optimize Nozzle Geometry for Patient Interaction in the Design Development of a Unit Dose Nasal SprayP9
Lei Mao
Development of Albuterol Sulfate Pressurized Metered Dose Inhalers using a Low Global Warming Potential Propellant 1,1-difluoroethane (HFA152a)P15
Lei Mao
Development of Beclomethasone Dipropionate Pressurized Metered Dose Inhalers using a Low Global Warming Potential Propellant, 1,3,3,3-tetrafluoropropene (HFO1234ze)P16
Benjamin Thorne
Investigating the Impact of Device Design and Propellant Choice on the Aerosolization of Fluticasone Propionate Suspensions in HFA152a and HFO1234zeP10
Jufang Xu
Aerodynamic Characteristics of Spiriva® Handihaler® at Simulated Breathing Patterns of COPD and Healthy Subjects, and at a Constant Inhalation Flow using One Capsule per DeterminationP16
Mirjam Kobler
Advancing DPI Technology: A Modular Approach on Optimizing Capsule Movement for Improved PerformanceP9
P9
Irene Rossi
Ellipta® Blister Device: A Re-Assembly Set of Tools for Early In Vitro Comparative Studies of a Complex Pre-Metered Dry Powder InhalerP3
Erik Boldt and Gregory Smith
Two Isn’t Always Better Than One: A Single-Actuation Salbutamol Sulfate Metered Dose Inhaler Using Low-GWP Propellant HFO-1234ze(E)P18
Patricia Henriques and Dina Morais
Systemic Nasal Absorption of Amorphous Solid Dispersions: Supersaturating Systems for Fast Onset of Action of Poorly Soluble Drugs through the Nasal MucosaP16
Maria Ines Lopes and Joao Pires
Drug Load Influence on Aerodynamic Properties of High Dosage DPIs: A Case Study of an Aminoglycoside Model DrugP24
Alexandre Ribeiro
Differential Permeability of Dry Solid and Aqueous Suspensions of Fluticasone Propionate Through A549 Alveolar Epithelial CellsP4
Lidia Santos and Claudia Costa
Understanding Leucine Encapsulation in Dry Powder Inhaler Microparticles via Surface Characterization TechniquesP25
Måns Österberg Widerstrand and Jakob Samsøe
Novel Inhaled Anti-Viral Against SARS-CoV-2: Feasibility of Developing a Nanofitin Dry Powder Formulation for Pulmonary Delivery using the ICOone Single Dose Dry Powder InhalerP26
ImmuONE
Louis Scott and Ewelina Hoffman
High-Content Image Analysis for Phenotypic Characterization of Foamy Macrophage Responses of Alveolar Macrophages to AmiodaroneP2
InformiX Pharma
Parmesh Gajjar and Darragh Murnane
Novel Insight into the Microstructure of Fines-Only Formulations using X-ray Computed Tomography with Machine LearningP1
Barry Clements
The Impact of the Universal Spacer System on Efficiency and Reliability of Dose Delivery of Inhaled Nebulized AerosolsP2
Svetlana Lyapustina
Regulatory Topics in Nasal Product Development: Pediatrics and Reliability ExpectationsP13
Jolyon Mitchell
Laser Diffraction Size Analysis of Products for Nasal Inhalation: A Survey of Expert UsersP12
Johannes Gutenberg-Universität Mainz
P8
James Drake
Practical Considerations for Conducting Successful In Vitro Bioequivalence Studies on InhalersP1
Sana Hosseini and Kimberly Shepard
Formulation of an Intranasal Dry Powder Vaccine Candidate for TuberculosisP1
Neerja Zambare and Kimberly Shepard
Manufacturability of Intranasal Dry Powders Spray Dried from Aqueous SolutionsP8
Ludwig-Maximilians-University Munich
Katrin Wiebe and Simone Carneiro
Impact of Vibrating Mesh Nebulization on the Physicochemical Properties of mRNA and siRNA Lipid Nanoparticle FormulationsP6
P28
Macquarie University
Chun Yuen Jerry Wong
Enhancing Nose-to-Brain Drug Delivery: A Comparative Study of Peptide Formulations Using a Multidose Nasal SprayP5
Medisch Spectrum Twente
Dumiana Chamaon and Martijn F. Grinovero
Validation of the RS01X™ Smart Inhaler in a Clinical SettingP11
Monash University
Daniel Duke
Effects of Low Global Warming Potential Propellants HFA152a and HFO1234ze(E) on the Morphology of Suspension Based Pressurized Metered Dose Inhaler SpraysP6
Monash University
Daniel Duke and Lingzhe Rao
Manipulation of pMDI Spray Morphology via Orifice Length Variation with Propellants HFA134a, HFA227, HFA152a and HFO1234ze(E)P7
Monash University
P2
Monash University
Swetha Chowdary Vutlapalli and Daniel Duke
Measurement of Vapor Pressure and Viscosity of Ethanol in HFA134a, HFA152a, and HFO1234ze(E) Mixtures used in pMDIsP11
Will Ganley and Nuria Manzano
Comparative Assessment of Plume Velocity in pMDI Solutions: A Study using Phase Doppler Anemometry and SprayView AnalysisP8
Will Ganley
Utilizing Physiologically-based Modeling for the Design of an Inhaled Powder Formulation of Imipenem Aimed at Maximizing the Dose Delivered to the Lung Lining FluidP12
Orexo AB
Jonas Sävmarker
Spray Dried Amorphous Epinephrine Nasal Powder for the Acute Treatment of AnaphylaxisP6
Daniel Lewis
Case Studies on Reformulation of BDP MDIs using Low GWP Propellants HFO1234ze and HFA152aP14
Andrea Winzen and Martin Schlun
Aerosol Performance and Usability Evaluation of New Pediatric Facemasks for a Valved Holding ChamberP17
Deborah Jones and Timothy Fallon
Inhalation and Exhalation Airflow Resistance of Valved Holding ChambersP4
Lynn Jordan
Methodology for Measurement of Evaporation Fraction and Evaporation Rate: A Comparison of HFA-134a and HFA-152a pMDI FormulationsP5
Carolina Dantas
Examining User Breathing Patterns During Nebulization with a Guided Inhalation ManeuverP3
Purdue University
Kinnari Arte
Impact of L-leucine on Stability and Aerosol Performance of Dry Powder Protein FormulationsP4
Purdue University
Shruti Sawant
Liposomal Formulation Reduces Cell Uptake of Bacteriophage in a Lung Epithelial Cell ModelP3
Resyca
Nicolas Buchmann
Assessing the Variability of In Silico Lung Deposition Predictions When Inhaling from Soft Mist Inhalers with Various Air Flow ResistancesP7
RTI International
Sara Maloney Norcross
Physicochemical and Aerodynamic Stability of Spray Dried Tigecycline Inhalation Powder for the Treatment of Pulmonary Nontuberculous Mycobacterial InfectionsP5
P10
St. John's University
Alec Diorio and Alan Watts
The Anti-Microbial Peptide, H1b, for Non-Small Cell Lung Cancer Treatment: Dry Powder Formulation Development And CharacterizationP6
The University of Texas at Austin
Varsha Nair and Rex Moore
Lipid-Based Spray Dried Microparticles of Monoclonal Antibodies for InhalationP7
The University of Texas at Austin
Mike Sandoval and Alan Watts
Drum Filling of Thin-Film Freeze-Dried Monoclonal Antibody Powders into a Nasal Spray SystemP10
The University of Texas at Austin
P8
Mark Nagel
Effect of Flow Rate on Emitted Aerodynamic Particle Size Distribution from a Dry Powder Inhaler Delivering a Short-Acting Beta2 Agonist as MonotherapyP12
U.S. Food & Drug Administration
P10
U.S. Food & Drug Administration
Steven Chopski
Novel Method for Aerodynamic Particle Size Distribution Measurements from Respimat® InhalersP5
U.S. Food & Drug Administration
Nicholas Holtgrewe
Development of an In Vitro Method for In Vivo Prediction of Regional Deposition of Nasal PowdersP11
U.S. Food & Drug Administration
Nathan Reed
Characterizing Adasuve® (Loxapine, 10 mg) Inhalation Powder Particle Size Distribution Using Laser DiffractionP11
U.S. Food & Drug Administration
Ross Walenga
Sensitivity of Charcoal Block PK Metrics to Differences in Regional Deposition for Budesonide and Formoterol Fumarate DihydrateP9
Universidade Estadual de Campinas
Laura Oliveira Nascimento
Effects of Surfactant Coating on Levofloxacin-Loaded Nanoparticles: Impact on Physicochemical Properties and In Vitro Cell Viability of Pulmonary Cells P4
Universidade Estadual de Campinas
Victoria Soares Soeiro
Enhancing Polymeric Nanodispersions for Improved Doxycycline Efficacy Against Lung Pathogen BiofilmsP5
University of Alabama at Birmingham
Blessy Joseph
The Use of Atomic Force Microscope-Infrared Spectroscopy to Assess Co-Localization of Fluticasone/Salmeterol/Lactose in Advair Diskus® 100/50 FormulationsP13
University of Bristol
Yiliang Jiang
Tandem Aerodynamic Particle Sizers Method for the Characterization of Aerosol Dynamics at Different Relative HumiditiesP5
University of Hong Kong
Han Cong Seow
The Influence of Salts on Spray Dried Powder for Nasal Inhalation: Aerosol Characterization with 3D-Printed Nasal ReplicaP14
University of Michigan
Nishant Shah
Evaluating Published Artificial Mucus Models for Understanding Predictability of Inhaled Drug Delivery DynamicsP7
University of Michigan
P15
University of Oklahoma
Alexa Beathard
Aerosol Performance of OHet72 Nanosuspensions Nebulized into a Custom-Made Nose-Only Dosing ChamberP6
University of Parma
P18
University of Parma
Francesca Buttini
Effect of Ethanol Content and Actuator Orifice Diameter on the Performance of Salbutamol Sulfate pMDI Suspensions in HFO1234ze(E)P2
University of Parma
P17
University of Sydney
Dipesh Khanal
Optical Photothermal Infrared Spectroscopic Assessment of Fluticasone/Salmeterol/Lactose Co-Association in Advair Diskus® and Wixela Inhub®P14
P15
Vast Therapeutics
P8
Fraser Carr
Exploration of Alternative Methodologies for Spray Pattern Evaluation in a Budesonide/Formoterol Fumarate Dihydrate pMDIP6
Raneem Aldaqqa
Designing mRNA Lipid Nanoparticles for Tumor Associated Macrophages: Towards Immunotherapies for the Treatment of Osteosarcoma Lung MetastasesP9
Caleb Dalton
Pharmaceutical Aerosol Deposition in a Stainless-Steel Version of the VCU Mouth-Throat ModelsP7
Caleb Dalton
Spray Characterization of Low Volume Air-Jet Dry Powder Inhaler Devices for the Delivery of a Synthetic Lung Surfactant Powder FormulationP19
Victoria Garcia
Locally Administered Gemcitabine Chemotherapy for the Treatment of Osteosarcoma Lung MetastasesP10
Felicia Hall
Comparison of In Vitro Aerosol Performance and Powder Characteristics of a Synthetic Lung Surfactant Powder Aerosol Formulation Produced using Two Spray Drying MethodsP20
Rudra Pangeni
Efficient Delivery of Powder Aerosol to the Lungs of Small Animals with a New Air-Jet Dry Powder InsufflatorP21
Surendra Poudel
In Vivo Efficacy of Tobramycin Excipient Enhanced Growth Dry Powder Aerosol in Pseudomonas Aeruginosa Lung Infection ModelP22
Masahiro Sakagami
A Novel Hybrid Molecule of Melatonin and Curcumin: In Vivo Therapeutic Intervention in the Rat Model of Lung Fibrosis with Local Lung DeliveryP1
Morgan Thomas
Advancements in Complete-Airway Modeling of Pharmaceutical Aerosols: Implementation of a Tracheobronchial Voluming-Filling AlgorithmP8
Woolcock Institute of Medical Research
Patrick He
Comparison of In Vitro Aerosol Deposition by Salbutamol pMDI with Corrugated Tubing and Commercial SpacerP12